SERUM THYMIDINE KINASE AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH MULTIPLE MYELOMA
Author:
Publisher
Wiley
Subject
Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1989.tb00251.x/fullpdf
Reference24 articles.
1. A clinical staging system for multiple myeloma;Durie;Cancer,1975
2. Staging systems for multiple myeloma: a comparison;Gassman;Br J Haematol,1985
3. Indication for therapy in multiple myeloma: should it be stage or stability;Joshua;Lancet,1985
4. Pretreatment tumour mass, cell kinetics and prognosis in multiple myeloma;Durie;Blood,1980
5. Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma;Leonard;Int J Cancer,1979
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular markers in cancer;Clinica Chimica Acta;2022-07
2. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10;Blood;2001-11-15
3. Thymidine kinase: diagnostic and prognostic potential;Expert Review of Molecular Diagnostics;2001-11
4. PROGNOSTIC FACTORS IN MULTIPLE MYELOMA;Hematology/Oncology Clinics of North America;1999-12
5. Longitudinal analysis of circulating myeloma cells detected by allele specific mRNA in situ hybridization;American Journal of Hematology;1998-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3